Clinical Trial Update: Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of risedronate for painful periprosthetic resorption of the hip prosthesis; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Prosthesis-related Complications
• Prosthesis Loosening

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Prosthesis Loosening | Phase 3 | Status: TERMINATED